Atom Investors LP Vaxart, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $2,727 - $8,144	-3,636 Reduced 20.48%	14,121 $13,000
Q3 2022 Nov 08, 2022	BUY	$2.09 - $4.5 $37,112 - $79,906	17,757 New	17,757 $39,000
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $85,576 - $125,734	-12,830 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $64,919 - $138,307	12,830 New	12,830 $96,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.